Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of
Markets Covered in the Report 15
3.1 In Vitro Diagnostics Devices 15
3.2 Clinical Chemistry Test Reagents 15
3.2.1 Laboratory Reagents 15
3.2.2 Clinical Chemistry Calibrators and Controls 15
3.2.3 Clinical
Chemistry Rapid Tests 15
3.3 Immunochemistry Test Reagents 15
3.3.1
Disease Specific Markers 15
3.3.2 Disease Specific Test Reagents 16
3.3.3 Drug Related Testing Reagents 16
3.3.4 Hormone Related Testing
Reagents 17
3.3.5 Immunochemistry Calibrators and Controls 17
3.3.6
Immunochemistry Rapid Tests 17
3.4 Blood Test Reagents 17
3.4.1
Hematology Test Reagents 17
3.4.2 Hemostasis Test Reagents 18
3.4.3
Tissue Typing Reagents 18
3.4.4 Monoclonal Antibodies 19
3.4.5
Cytokines and Immunomodulators 19
3.4.6 Histology and Cytology Reagents
19
3.5 Microbiology Test Reagents 19
3.5.1 Bacteriology Test Reagents
19
3.5.2 Microbiology Calibrators and Controls 19
3.5.3 Microbiology
Rapid Tests 20
3.6 Infectious Immunology Test Reagents 20
3.6.1
Bacteriology 20
3.6.2 Virology 20
3.6.3 Parasitology 20
3.6.4
Infectious Immunology Calibrators and Controls 20
3.6.5 Infectious
Immunology Rapid Tests 20
3.7 Genetic Test Reagents 20
3.8 Self
Testing 21
3.9 Instruments 21
4 Healthcare Sector Review 22
4.1
Healthcare Expenditure 22
4.2 Healthcare Infrastructure 25
4.3
Healthcare Policy 29
5 Regulation System 30
5.1 Medical Equipment
Approval Process 30
5.1.1 Classification 30
5.1.2 Registration and
Conformity Assessment 37
5.2 Advertising 39
5.3 Labeling and Packaging
40
5.4 Post-market Surveillance 41
5.5 Registration Fee 41
6
Pricing and Reimbursement 48
7 Distribution Structure 49
8 In Vitro
Diagnostics In Australia 50
8.1 In Vitro Diagnostics, Australia, Overall
Revenue ($ mn), 2000-2015 50
8.2 In Vitro Diagnostics, Australia Company
Share (2006-2007) 56
9 Blood Test Reagents In Australia 57
9.1 Blood
Test Reagents Overall Revenue (2000-2015) 57
9.1.1 Haematology Test
Reagents Revenue (2000-2015) 61
9.1.2 Hemostasis Test Reagents Revenue
(2000-2015) 63
9.2 Blood Test Reagents Distribution Share (2007-2008)
65
9.3 Blood Test Reagents, Australia, Company Share (2006-2007) 66
10
Clinical Chemistry Test Reagents In Australia 67
10.1 Clinical Chemistry
Test Reagents Overall Revenue (2000-2015) 67
10.2 Clinical Chemistry Test
Reagents Distribution Share (2007-2008) 69
10.3 Clinical Chemistry Test
Reagents, Australia, Company Share (2006-2007) 70
11 Genetic Test Reagents
In Australia 71
11.1 Genetic Test Reagents Overall Revenue (2000-2015)
71
11.2 Genetic Test Reagents Distribution Share (2007-2008) 73
11.3
Genetic Test Reagents, Australia, Company Share (2006-2007) 74
12
Immunochemistry Test Reagents In Australia 75
12.1 Immunochemistry Test
Reagents Overall Revenue (2000-2015) 75
12.1.1 Disease Specific Markers
Revenue (2000-2015) 79
12.1.2 Disease Specific Test Reagents Revenue
(2000-2015) 81
12.1.3 Drug Related Testing Reagents Revenue (2000-2015)
83
12.1.4 Hormone Related Testing Reagents Revenue (2000-2015) 85
12.2
Immunochemistry Test Reagents Distribution Share (2007-2008) 87
12.3
Immunochemistry Test Reagents, Australia, Company Share (2006-2007) 88
13
Infectious Immunology Test Reagents In Australia 89
13.1 Infectious
Immunology Test Reagents Overall Revenue (2000-2015) 89
13.1.1 Virology
Revenue (2000-2015) 93
13.2 Infectious Immunology Test Reagents
Distribution Share (2007-2008) 95
13.3 Infectious Immunology Test
Reagents, Australia, Company Share (2006-2007) 96
14 Instruments In
Australia 97
14.1 Instruments Overall Revenue (2000-2015) 97
14.2
Instruments Distribution Share (2007-2008) 99
15 Microbiology Test
Reagents In Australia 100
15.1 Microbiology Test Reagents Overall Revenue
(2000-2015) 100
15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
102
15.2 Microbiology Test Reagents Distribution Share (2007-2008) 104
15.3 Microbiology Test Reagents, Australia, Company Share (2006-2007) 105
16 Self Testing In Australia 106
16.1 Self Testing Overall Revenue
(2000-2015) 106
16.2 Self Testing Distribution Share (2007-2008) 108
16.3 Self Testing, Australia, Company Share (2006-2007) 109
17 Overview of
Key Companies in Australia In Vitro Diagnostics Market 110
17.1 F.
Hoffmann-La Roche Ltd. Company Profile 110
17.1.1 Company Overview 110
17.1.2 Value Chain Analysis 111
17.2 Abbott Laboratories Company Profile
114
17.2.1 Company Overview 114
17.2.2 Value Chain Analysis 114
17.2.3 Abbott Laboratories Pipeline Products 116
17.3 Beckman Coulter,
Inc. Company Profile 118
17.3.1 Company Overview 118
17.3.2 Value
Chain Analysis 118
17.3.3 Beckman Coulter, Inc. Pipeline Products 120
17.4 Dade Behring Holdings, Inc. Company Profile 122
17.4.1 Company
Overview 122
17.5 Ortho-Clinical Diagnostics Inc. Company Profile 123
17.5.1 Company Overview 123
17.5.2 Ortho-Clinical Diagnostics Inc.
Pipeline Products 123
17.6 bioMerieux S.A. Company Profile 124
17.6.1
Company Overview 124
17.6.2 Value Chain Analysis 125
17.7 Astral
Scientific Pty Ltd Company Profile 128
17.7.1 Company Overview 128
17.8 Banksia Scientific Pte Ltd Company Profile 128
17.8.1 Company
Overview 128
17.9 BioLayer Corporation Limited Company Profile 128
17.9.1 Company Overview 128
17.10 Cellabs Pty Ltd Company Profile 128
17.10.1 Company Overview 128
17.11 Diagnostic Technology Company Profile
129
17.11.1 Company Overview 129
17.12 Enterix Australia Pty Ltd
Company Profile 129
17.12.1 Company Overview 129
17.13 Fermiscan
Holdings Limited Company Profile 129
17.13.1 Company Overview 129
17.13.2 Fermiscan Holdings Limited Pipeline Products 129
17.14 GeneWorks
Pty. Ltd. Company Profile 131
17.14.1 Company Overview 131
17.15
HealthLinx Limited Company Profile 131
17.15.1 Company Overview 131
17.15.2 HealthLinx Limited Pipeline Products 131
17.16 Panbio Limited
Company Profile 133
17.16.1 Company Overview 133
17.16.2 Panbio
Limited Pipeline Products 133
17.17 Vision BioSystems Ltd Company Profile
134
17.17.1 Company Overview 134
17.18 Proteome Systems Limited
Company Profile 135
17.18.1 Company Overview 135
17.18.2 Proteome
Systems Limited Pipeline Products 135
17.19 Universal Biosensors, Inc.
Company Profile 136
17.19.1 Company Overview 136
17.19.2 Universal
Biosensors, Inc. Pipeline Products 136
18 Financial Deals Landscape
137
18.1 Acquisition 137
18.1.1 QIAGEN Acquires Corbett Life Science
137
18.2 Equity Offerings 138
18.2.1 Sonic Healthcare Completes
Private Placement Of $283.28 Million 138
18.2.2 Proteome Systems Completes
Private Placement Of $2.17 Million 139
18.2.3 CSL Completes Private
Placement Of $1,517.63 Million 141
18.3 Partnerships 142
18.3.1
Circadian Technologies Enters Into An Agreement With Healthscope 142
18.3.2 ProGenTech Signs Licensing Agreement With Human Genetic Signatures
143
19 Recent Developments 144
19.1 Strategy and Business Planning
144
19.1.1 May 20, 2008: Aperio Opens Operations Center In Australia And
New Zealand 144
19.2 Product Approvals 144
19.2.1 Dec 15, 2008: Itamar
Medical' s Endo-PAT2000 Approved For Use By Australian Government' s TGA 144
20 Appendix 145
20.1 Global Markets Direct Research Methodology 145
20.2 Coverage 146
20.3 Secondary Research 146
20.4 Primary Research
147
20.5 Models 147
20.6 Forecasts 148
20.7 Expert Panel
Validation 148
20.8 Currency Conversion 149
20.9 Contact Us 150
20.10 Disclaimer 150
1.1 List of Tables
Table 1: Healthcare
Infrastructure in Australia, 2005 25
Table 2: Healthcare Personnel in
Australia, 2005 26
Table 3: Hospital Wards by Specialty in Australia,
2003-2007 27
Table 4: Doctors by Specialty in Australia, 2003-2007 28
Table 5: Conformity Assessment of Medical Devices based Device Class, in
Australia, 2007 39
Table 6: Fee for Registered Device in Australia, 2007
41
Table 7: Fee for Device Clinical Trial in Australia, 2007 42
Table
8: Evaluation Fee for High and Low Level Registration of Medical Device in
Australia, 2007 42
Table 9: Evaluation Fee for Variation Registration of
Medical Device in Australia, 2007 43
Table 10: Fee for Registration of
Listed Devices in Australia, 2007 43
Table 11: Fee for Registration of
Listed Devices for Export Only in Australia, 2007 44
Table 12: Fee for
Registration of Included Devices in Australia, 2007 44
Table 13: Fee for
Initial Conformity Assessment of Medical Device in Australia, 2007 44
Table 14: Fee for Medical Device Changes Conformity Assessment in Australia,
2007 45
Table 15: Fee for Medical Device Conformity Assessment
Surveillance Audit in Australia, 2007 45
Table 16: Fee for Medical Device
Conformity Assessment Review Certificate in Australia, 2007 45
Table 17:
Fee for Initial Conformity Assessment of Medical Device Components in
Australia, 2007 46
Table 18: Fee for Conformity Assessment of Changes in
Medical Device Components in Australia, 2007 46
Table 19: Fee for Abridged
Conformity Assessment of Medical Device Components in Australia, 2007 46
Table 20: Fee for Inclusion of Medical Device in the Register in Australia,
2007 47
Table 21: Fee for ARTG Inclusion for Medical Device in Australia,
2007 47
Table 22: In Vitro Diagnostics, Australia, Overall Revenue ($
mn), 2000-2015 50
Table 23: In Vitro Diagnostics, Australia,
Cross-Category Analysis, 2000-2015 51
Table 24: In Vitro Diagnostics,
Australia, Overall Revenue ($ mn), Historic, 2000-2008 53
Table 25:
In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
55
Table 26: In Vitro Diagnostics, Australia Company Share by Revenue
($ mn), 2006-2007 56
Table 27: Blood Test Reagents, Australia,
Revenue ($ mn) by Segment , Historic, 2000-2008 58
Table 28: Blood
Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
60
Table 29: Haematology Test Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 61
Table 30: Haematology Test
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 62
Table 31: Hemostasis Test Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 63
Table 32: Hemostasis Test
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 64
Table 33: Blood Test Reagents, Australia, Distribution Share by Revenue
($mn), 2007-2008 65
Table 34: Blood Test Reagents, Australia, Company
Share by Revenue ($ mn), 2006-2007 66
Table 35: Clinical Chemistry
Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
67
Table 36: Clinical Chemistry Test Reagents, Australia, Revenue ($
mn) by Segment , Forecast, 2008-2015 68
Table 37: Clinical Chemistry
Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
69
Table 38: Clinical Chemistry Test Reagents, Australia, Company
Share by Revenue ($ mn), 2006-2007 70
Table 39: Genetic Test
Reagents, Australia, Revenue ($ mn), Historic, 2000-2008 71
Table 40:
Genetic Test Reagents, Australia, Revenue ($ mn), Forecast, 2008-2015 72
Table 41: Genetic Test Reagents, Australia, Distribution Share by Revenue
($mn), 2007-2008 73
Table 42: Genetic Test Reagents, Australia,
Company Share by Revenue ($ mn), 2006-2007 74
Table 43:
Immunochemistry Test Reagents, Australia, Revenue ($ mn) by Segment ,
Historic, 2000-2008 76
Table 44: Immunochemistry Test Reagents,
Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015 78
Table 45:
Disease Specific Markers, Australia, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 79
Table 46: Disease Specific Markers, Australia,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Table 47:
Disease Specific Test Reagents, Australia, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 81
Table 48: Disease Specific Test Reagents,
Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Table 49:
Drug Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 83
Table 50: Drug Related Testing Reagents,
Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 84
Table 51:
Hormone Related Testing Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 85
Table 52: Hormone Related Testing
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 86
Table 53: Immunochemistry Test Reagents, Australia, Distribution Share by
Revenue ($mn), 2007-2008 87
Table 54: Immunochemistry Test Reagents,
Australia, Company Share by Revenue ($ mn), 2006-2007 88
Table 55:
Infectious Immunology Test Reagents, Australia, Revenue ($ mn) by Segment ,
Historic, 2000-2008 90
Table 56: Infectious Immunology Test Reagents,
Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015 92
Table 57:
Virology, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
93
Table 58: Virology, Australia, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 94
Table 59: Infectious Immunology Test Reagents,
Australia, Distribution Share by Revenue ($mn), 2007-2008 95
Table 60:
Infectious Immunology Test Reagents, Australia, Company Share by Revenue ($
mn), 2006-2007 96
Table 61: Instruments, Australia, Revenue ($ mn),
Historic, 2000-2008 97
Table 62: Instruments, Australia, Revenue ($
mn), Forecast, 2008-2015 98
Table 63: Instruments, Australia,
Distribution Share by Revenue ($mn), 2007-2008 99
Table 64:
Microbiology Test Reagents, Australia, Revenue ($ mn) by Segment , Historic,
2000-2008 100
Table 65: Microbiology Test Reagents, Australia,
Revenue ($ mn) by Segment , Forecast, 2008-2015 101
Table 66:
Bacteriology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 102
Table 67: Bacteriology Test Reagents,
Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 103
Table
68: Microbiology Test Reagents, Australia, Distribution Share by Revenue
($mn), 2007-2008 104
Table 69: Microbiology Test Reagents, Australia,
Company Share by Revenue ($ mn), 2006-2007 105
Table 70: Self
Testing, Australia, Revenue ($ mn), Historic, 2000-2008 106
Table 71:
Self Testing, Australia, Revenue ($ mn), Forecast, 2008-2015 107
Table 72:
Self Testing, Australia, Distribution Share by Revenue ($mn), 2007-2008
108
Table 73: Self Testing, Australia, Company Share by Revenue ($
mn), 2006-2007 109
Table 74: Abbott Laboratories Pipeline Products
by Equipment Type 116
Table 75: Abbott Laboratories Pipeline
Products By Development Stage 117
Table 76: Abbott Laboratories
Pipeline Products By Therapy Area 117
Table 77: Abbott Laboratories
Pipeline Products By Clinical Trials 117
Table 78: Abbott
Laboratories Pipeline Products By News Summary 117
Table 79: Beckman
Coulter, Inc. Pipeline Products by Equipment Type 120
Table 80:
Beckman Coulter, Inc. Pipeline Products By Development Stage 120
Table 81:
Beckman Coulter, Inc. Pipeline Products By Therapy Area 121
Table 82:
Beckman Coulter, Inc. Pipeline Products By News Summary 121
Table 83:
Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
123
Table 84: Ortho-Clinical Diagnostics Inc. Pipeline Products By
Development Stage 123
Table 85: Ortho-Clinical Diagnostics Inc.
Pipeline Products By Therapy Area 123
Table 86: Ortho-Clinical
Diagnostics Inc. Pipeline Products By News Summary 123
Table 87:
Fermiscan Holdings Limited Pipeline Products by Equipment Type 129
Table
88: Fermiscan Holdings Limited Pipeline Products By Development Stage
130
Table 89: Fermiscan Holdings Limited Pipeline Products By Therapy
Area 130
Table 90: Fermiscan Holdings Limited Pipeline Products By
Clinical Trials 130
Table 91: Fermiscan Holdings Limited Pipeline
Products By News Summary 130
Table 92: HealthLinx Limited Pipeline
Products by Equipment Type 131
Table 93: HealthLinx Limited Pipeline
Products By Development Stage 131
Table 94: HealthLinx Limited
Pipeline Products By Therapy Area 132
Table 95: HealthLinx Limited
Pipeline Products By Clinical Trials 132
Table 96: Panbio Limited
Pipeline Products by Equipment Type 133
Table 97: Panbio Limited
Pipeline Products By Development Stage 133
Table 98: Panbio Limited
Pipeline Products By Therapy Area 133
Table 99: Panbio Limited
Pipeline Products By News Summary 134
Table 100: Proteome Systems
Limited Pipeline Products by Equipment Type 135
Table 101: Proteome
Systems Limited Pipeline Products By Development Stage 135
Table 102:
Proteome Systems Limited Pipeline Products By Therapy Area 135
Table 103:
Proteome Systems Limited Pipeline Products By News Summary 135
Table
104: Universal Biosensors, Inc. Pipeline Products by Equipment Type
136
Table 105: Universal Biosensors, Inc. Pipeline Products By
Development Stage 136
Table 106: Universal Biosensors, Inc. Pipeline
Products By Therapy Area 136
Table 107: QIAGEN Acquires Corbett Life
Science 137
Table 108: Sonic Healthcare Completes Private Placement
Of $283.28 Million 138
Table 109: Proteome Systems Completes Private
Placement Of $2.17 Million 139
Table 110: CSL Completes Private
Placement Of $1,517.63 Million 141
Table 111: Circadian Technologies
Enters Into An Agreement With Healthscope 142
Table 112: ProGenTech
Signs Licensing Agreement With Human Genetic Signatures 143
Table 113:
USD to Local Currency, Average Exchange Rate 2008 149
1.2 List of
Figures
Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005
23
Figure 2: Healthcare Financing Framework in Australia, 2007 24
Figure 3: Healthcare System in Australia, 2007 29
Figure 4: Classification
of Medical Devices in Australia, 2007 32
Figure 5: Classification of
Noninvasive Devices in Australia, 2007 33
Figure 6: Classification of
Invasive Devices in Australia, 2007 34
Figure 7: Classification of
Invasive Devices in Australia, 2007 35
Figure 8: Classification of Active
Devices in Australia, 2007 36
Figure 9: Classification of Special Medical
Devices in Australia, 2007 37
Figure 10: Conformity Assessment Procedure
for Medical Devices in Australia, 2007 38
Figure 11: In Vitro
Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015 50
Figure 12:
In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015 51
Figure 13: In Vitro Diagnostics, Australia, Overall Revenue ($ mn),
Historic, 2000-2008 52
Figure 14: In Vitro Diagnostics, Australia,
Overall Revenue ($ mn), Forecast, 2008-2015 54
Figure 15: In Vitro
Diagnostics, Australia Company Share (%), 2007 56
Figure 16: Blood
Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
57
Figure 17: Blood Test Reagents, Australia, Revenue ($ mn) by
Segment , Forecast, 2008-2015 59
Figure 18: Haematology Test
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 61
Figure 19: Haematology Test Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 62
Figure 20: Hemostasis Test
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Figure 21: Hemostasis Test Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 64
Figure 22: Blood Test Reagents,
Australia, Company Share (%), 2007 66
Figure 23: Clinical Chemistry
Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
67
Figure 24: Clinical Chemistry Test Reagents, Australia, Revenue ($
mn) by Segment , Forecast, 2008-2015 68
Figure 25: Clinical Chemistry
Test Reagents, Australia, Company Share (%), 2007 70
Figure 26:
Genetic Test Reagents, Australia, Revenue ($ mn), Historic, 2000-2008 71
Figure 27: Genetic Test Reagents, Australia, Revenue ($ mn), Forecast,
2008-2015 72
Figure 28: Genetic Test Reagents, Australia, Company
Share (%), 2007 74
Figure 29: Immunochemistry Test Reagents,
Australia, Revenue ($ mn) by Segment , Historic, 2000-2008 75
Figure 30:
Immunochemistry Test Reagents, Australia, Revenue ($ mn) by Segment ,
Forecast, 2008-2015 77
Figure 31: Disease Specific Markers,
Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 79
Figure
32: Disease Specific Markers, Australia, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 80
Figure 33: Disease Specific Test Reagents,
Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Figure
34: Disease Specific Test Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 82
Figure 35: Drug Related Testing
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 83
Figure 36: Drug Related Testing Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 84
Figure 37: Hormone Related
Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 85
Figure 38: Hormone Related Testing Reagents, Australia,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 86
Figure 39:
Immunochemistry Test Reagents, Australia, Company Share (%), 2007 88
Figure 40: Infectious Immunology Test Reagents, Australia, Revenue ($ mn)
by Segment , Historic, 2000-2008 89
Figure 41: Infectious Immunology
Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
91
Figure 42: Virology, Australia, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 93
Figure 43: Virology, Australia, Revenue ($ mn)
by Sub-Segment, Forecast, 2008-2015 94
Figure 44: Infectious
Immunology Test Reagents, Australia, Company Share (%), 2007 96
Figure 45:
Instruments, Australia, Revenue ($ mn), Historic, 2000-2008 97
Figure
46: Instruments, Australia, Revenue ($ mn), Forecast, 2008-2015 98
Figure 47: Microbiology Test Reagents, Australia, Revenue ($ mn) by
Segment , Historic, 2000-2008 100
Figure 48: Microbiology Test
Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015 101
Figure 49: Bacteriology Test Reagents, Australia, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 102
Figure 50: Bacteriology Test
Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
103
Figure 51: Microbiology Test Reagents, Australia, Company Share
(%), 2007 105
Figure 52: Self Testing, Australia, Revenue ($ mn),
Historic, 2000-2008 106
Figure 53: Self Testing, Australia, Revenue
($ mn), Forecast, 2008-2015 107
Figure 54: Self Testing, Australia,
Company Share (%), 2007 109
Figure 55: F. Hoffmann-La Roche Ltd Value
Chain Analysis 111
Figure 56: Abbott Laboratories Value Chain
Analysis 114
Figure 57: Beckman Coulter, Inc. Value Chain Analysis
118
Figure 58: Biomerieux Sa Value Chain Analysis 125
Figure 59:
Global Markets Direct Methodology 145
|
Related Report
|
View Cart
